Vistagen Therapeutics, Inc. (VTGN) Insider Trading -- Recent Executive & Director Transactions
5 insiders reported 8 Form 4 transactions for Vistagen Therapeutics, Inc. (VTGN) over the past 18 months (most recent 2026-07-02). Recent activity: Adler Reid G. (Chief Legal Officer) Buy 36,818 shares, Tressler Nick B. (Chief Financial Officer) Buy 11,712 shares, Singh Shawn (President and CEO) Buy 36,818 shares, Prince Joshua S. (Chief Operating Officer) Buy 4,386 shares, Anderson Cynthia Lynn (CHIEF FINANCIAL OFFICER) Buy 6,617 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Adler Reid G. | Chief Legal Officer | Buy | 36,818 | $7,073 |
| 2026-07-02 | Tressler Nick B. | Chief Financial Officer | Buy | 11,712 | $2,250 |
| 2026-07-02 | Singh Shawn | President and CEO | Buy | 36,818 | $7,073 |
| 2026-01-05 | Prince Joshua S. | Chief Operating Officer | Buy | 4,386 | $2,456 |
| 2025-07-01 | Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Buy | 6,617 | $11,249 |
| 2025-07-01 | Prince Joshua S. | Chief Operating Officer | Buy | 4,882 | $8,299 |
| 2025-07-01 | Adler Reid G. | Chief Legal Officer | Buy | 7,541 | $12,820 |
| 2025-07-01 | Singh Shawn | President and CEO | Buy | 7,541 | $12,820 |
Source: SEC Form 4 filings · as of 2026-07-02